Jingwu Xu

426 total citations
13 papers, 340 citations indexed

About

Jingwu Xu is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Jingwu Xu has authored 13 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Immunology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Jingwu Xu's work include Viral-associated cancers and disorders (8 papers), Immune Cell Function and Interaction (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). Jingwu Xu is often cited by papers focused on Viral-associated cancers and disorders (8 papers), Immune Cell Function and Interaction (5 papers) and Lymphoma Diagnosis and Treatment (3 papers). Jingwu Xu collaborates with scholars based in Canada, Malaysia and United States. Jingwu Xu's co-authors include Ali Ahmad, José Menézes, Mario D’Addario, U. Prasad, Emanuela Vaccher, Riccardo Dolcetti, James F. Jones, Rasheed Ahmad, Laurent Knafo and Towia A. Libermann and has published in prestigious journals such as The Journal of Immunology, Journal of Molecular Biology and Journal of Virology.

In The Last Decade

Jingwu Xu

13 papers receiving 334 citations

Peers

Jingwu Xu
Shidong Ma United States
Sujal Ghosh Germany
Anja M. Mehl United Kingdom
Kathleen R. Makielski United States
Kristy Wolniak United States
Ana Raykova Switzerland
Shidong Ma United States
Jingwu Xu
Citations per year, relative to Jingwu Xu Jingwu Xu (= 1×) peers Shidong Ma

Countries citing papers authored by Jingwu Xu

Since Specialization
Citations

This map shows the geographic impact of Jingwu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingwu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingwu Xu more than expected).

Fields of papers citing papers by Jingwu Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingwu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingwu Xu. The network helps show where Jingwu Xu may publish in the future.

Co-authorship network of co-authors of Jingwu Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jingwu Xu. A scholar is included among the top collaborators of Jingwu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingwu Xu. Jingwu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Mo, Zhiqiang, Qiao Li, Jian He, et al.. (2024). Prognostic model for unresectable hepatocellular carcinoma treated with dual PD-1 and angiogenesis blockade therapy. Journal for ImmunoTherapy of Cancer. 12(1). e008191–e008191. 3 indexed citations
4.
Subbramanian, Ramu A., Jingwu Xu, Emil Toma, et al.. (2002). Comparison of Human Immunodeficiency Virus (HIV)-Specific Infection-Enhancing and -Inhibiting Antibodies in AIDS Patients. Journal of Clinical Microbiology. 40(6). 2141–2146. 18 indexed citations
5.
D’Addario, Mario, Towia A. Libermann, Jingwu Xu, Ali Ahmad, & José Menézes. (2001). Epstein-Barr virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-κB and different signaling pathways. Journal of Molecular Biology. 308(3). 501–514. 45 indexed citations
6.
Xu, Jingwu, Ali Ahmad, Mario D’Addario, et al.. (2000). Analysis and Significance of Anti-Latent Membrane Protein-1 Antibodies in the Sera of Patients with EBV-Associated Diseases. The Journal of Immunology. 164(5). 2815–2822. 31 indexed citations
7.
Ahmad, Rasheed, Laurent Knafo, Jingwu Xu, et al.. (2000). Thrombin induces apoptosis in human tumor cells. International Journal of Cancer. 87(5). 707–715. 32 indexed citations
8.
Xu, Jingwu, Ali Ahmad, James F. Jones, et al.. (2000). Elevated Serum Transforming Growth Factor β1 Levels in Epstein-Barr Virus-Associated Diseases and Their Correlation with Virus-Specific Immunoglobulin A (IgA) and IgM. Journal of Virology. 74(5). 2443–2446. 35 indexed citations
9.
Xu, Jingwu, José Menézes, U. Prasad, & Ali Ahmad. (1999). Elevated serum levels of transforming growth factor β1 in Epstein‐Barr virus‐associated nasopharyngeal carcinoma patients. International Journal of Cancer. 84(4). 396–399. 61 indexed citations
10.
D’Addario, Mario, Ali Ahmad, Jingwu Xu, & J Menezes. (1999). Epstein‐Barr virus envelope glycoprotein gp350 induces NF‐κB activation and IL‐1β synthesis in human monocytes‐macrophages involving PKC and PI3‐K. The FASEB Journal. 13(15). 2203–2213. 30 indexed citations
11.
Menézes, José, et al.. (1999). Modulatory effects of human herpes virus-7 on cytokine synthesis and cell proliferation in human peripheral blood mononuclear cell cultures. Journal of Leukocyte Biology. 66(5). 822–828. 23 indexed citations
12.
Xu, Jingwu, Ali Ahmad, Mario D’Addario, et al.. (1998). The Epstein‐Barr Virus (EBV) major envelope glycoprotein gp350/220‐specific antibody reactivities in the sera of patients with different EBV‐associated diseases. International Journal of Cancer. 79(5). 481–486. 1 indexed citations
13.
Xu, Jingwu, Ali Ahmad, Mario D’Addario, et al.. (1998). The Epstein-Barr Virus (EBV) major envelope glycoprotein gp350/220-specific antibody reactivities in the sera of patients with different EBV-associated diseases. International Journal of Cancer. 79(5). 481–486. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026